Comparing the current results to its competitors, Airsculpt Technologies Inc reported Revenue decrease in the 2 quarter 2026 year on year by -2.53 %, despite the revenue increase by the most of its competitors of 7.47 %, recorded in the same quarter.
Airsculpt Technologies Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 1.35 %
Airsculpt Technologies Inc 's Comment on Competition and Industry Peers
The company competes with individual and small practice providers of traditional liposuction, national providers of minimally-invasive techniques, university and hospital systems, medical spas and centers, and beauty and rejuvenation centers offering body contouring services. It also competes with companies providing non-surgical fat reduction methods, including weight-loss drugs and other non-invasive weight loss and obesity treatments. Competition extends across patients and procedure offerings such as liposuction, abdominoplasty, gastric bypass surgery, weight-loss drugs, and non-surgical procedures utilizing cooling, injected medication, or heat to reduce fat cells. Additionally, the company competes for high-quality surgeons and other professionals in the body contouring and cosmetic surgery industry.
AbbVie Inc operates primarily as a global biopharmaceutical company, focusing on the research, development, manufacturing, and commercialization of advanced therapies and medications in critical areas such as immunology, oncology, neuroscience, and virology. The company aims to improve patient outcomes and address unmet medical needs by leveraging its scientific expertise and capabilities while providing value to stakeholders in the healthcare industry.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
Inmode Ltd is a medical technology company that specializes in developing and commercializing minimally invasive aesthetic and medical solutions. They primarily operate on a direct-to-consumer model, selling their devices to physicians, medical spas, and clinics. In addition to device sales, they generate recurring revenue through consumable product sales and service contracts for their devices.
Rollins Inc is a global provider of pest control services with a business model focused on comprehensive pest management solutions. The company offers residential and commercial services through its subsidiaries, addressing various pest-related issues such as termite control, wildlife management, and sanitation. Rollins Inc excels in providing reliable and professional assistance, ensuring customer satisfaction and maintaining long-term relationships.
Sources:
Airsculpt Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Airsculpt Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
